BMSC-EVs might be useful for treating SSc using miRNAs, which could alleviate ECM deposition and inflammatory cell infiltration by regulating the TGFβ and Wnt signaling pathways (53). This evidence concerns the gene TGFB1 and systemic sclerosis.